Abstract:ABSTRACT Heart failure is a major source of mortality in Duchenne muscular dystrophy (DMD). DMD arises from mutations that ablate expression of the protein dystrophin, which render the plasma membrane unusually fragile and prone to disruption. In DMD patients, repeated mechanical stress leads to membrane damage and cardiomyocyte loss. Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) offer the opportunity to study specific mutations in the context of a human cell, but these models can be improved by adding physiologic stressors. We modeled the primary defect underlying DMD by applying equibiaxial mechanical strain to DMD iPSC-CMs. DMD iPSC-CMs demonstrated an increased susceptibility to equibiaxial strain after 2 hours at 10% strain relative to healthy control cells, measured as increased lactate dehydrogenase (LDH) release. After 24 hours, both DMD and healthy control iPSC-CMs showed evidence of injury with release of LDH and cardiac troponin T. We exposed iPSC-CMs to recombinant annexin A6, a protein resealing agent, and found reduced LDH and troponin release in DMD and control iPSC-CMs that had been subjected to 24 hour strain at 10%. We used aptamer protein profiling of media collected from DMD and control iPSC-CMs and compared these results to serum protein profiling from DMD patients. We found a strong correlation between the proteins in DMD patient serum and media from DMD iPSC-CMs subjected to mechanical stress. By developing an injury assay that specifically targets an underlying mechanism of injury seen in DMD-related cardiomyopathy, we demonstrated the potential therapeutic efficacy of the protein membrane resealer, recombinant annexin A6, for the treatment of DMD-related cardiomyopathy and general cardiac injury.

Membrane Repair Assay for Human Skeletal Muscle Cells

A Novel Assay Reveals the Early Setting‐Up of Membrane Repair Machinery in Human Skeletal Muscle Cells

Membrane repair of human skeletal muscle cells requires Annexin-A5

Annexin-A6 in Membrane Repair of Human Skeletal Muscle Cell: A Role in the Cap Subdomain

Cell Membrane Repair Assay Using a Two-photon Laser Microscope

Trafficking of Annexins during Membrane Repair in Human Skeletal Muscle Cells

Plasma Membrane Repair in Health and Disease

Visualization of MG53-mediated Cell Membrane Repair Using in vivo and in vitro Systems

High-Throughput Microplate-Based Assay to Monitor Plasma Membrane Wounding and Repair

Annexins and Membrane Repair Dysfunctions in Muscular Dystrophies

Membrane Injury and Repair in the Muscular Dystrophies

Imaging Cell Membrane Injury and Subcellular Processes Involved in Repair

SIRT1 activitors ameliorate the ability of cell membrane repair.

Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy

Deficient Sarcolemma Repair in ALS: A Novel Mechanism with Therapeutic Potential

MEndR: An In Vitro Functional Assay to Predict In Vivo Muscle Stem Cell‐Mediated Repair

Microfluidic-assisted cyclic mechanical stimulation affects cellular membrane integrity in a human muscular dystrophy in vitro model

Dysferlin and muscle membrane repair

Recombinant annexin A6 promotes membrane repair in a stem cell derived-cardiomyocyte model of dystrophic cardiomyopathy

Membrane Repair: Mechanisms and Pathophysiology